Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Algernon’s business model is based on drug re-purposing, finding new uses for know drugs





 

Bullboard - Investor Discussion Forum Algernon Pharmaceuticals Inc C.AGN

Alternate Symbol(s):  AGNPF

Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N... see more

CSE:AGN - Post Discussion

View:
Post by nodaytrader on Jan 14, 2022 12:04pm

Price Drop

Price drops from 8.49 to 8.25 and guess who's involved?
Comment by fruiscante1 on Jan 14, 2022 2:20pm
I get the impression that there's not enough eyes on this board these days for guessing games, would you mind just posting the information? (not trying to be a smart a$$ - I'm genuinely interested) 
Comment by nodaytrader on Jan 17, 2022 4:06pm
 OK! Let me try and explain with two caveats. 1. I am not knowledgeable about stock trading although I do watch it https://www.thecse.com/en/listings/life-sciences/algernon-pharmaceuticals 2.  I am not suggesting that there is anything illegal going on but there may be valid questions to be raised. /> I think we both agree that that there some kind of price depression activity ...more  
Comment by C10H12N2 on Jan 17, 2022 6:13pm
My guess is you haven't watched the webinar today? Because that is by far the most relevant information. IMO, the primary menace for Algernon stock was Kulwant Malhi. It's said Algernon is now out of his millions of shares stock flipping portfolio. To date, the stock is moving ^up and ^up. What's your break even point/catalyst to suggest manipulation is no longer a problem? For me, it& ...more  
Comment by fruiscante1 on Jan 18, 2022 12:37am
Can anyone who saw it please provide a summary or any key takeaways? Thanks!
Comment by Goldhog on Jan 18, 2022 1:27am
Same. Thanks
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

Connect with C.AGN


CEO Clips: DMT Clinical Trial

CEO Q&A Interview with Chris Moreau

Investor Presentation

Download the latest Investor Presentaion

Algernon Highlights: The Watchlist

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >

Investment Opportunity

The Algernon Value Proposition



  • Advancing new drug treatments for billion dollar global disease markets.
  • Re-purposed compounds have a much lower risk of failing in human trials as a result of safety issues.
  • Conducting multiple phase II clinical trials.
  • Highly capital efficient business model.
  • Experienced management team & globally recognized medical advisory board.

Facebook